NCT07308587 Evaluation of Intercostal Neuralgia in Patients With Chest Tube Insertion After Traumatic Rib Fracture
| NCT ID | NCT07308587 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sunnybrook Health Sciences Centre |
| Condition | Intercostal Nerve Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-19 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-01-19 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Traumatic rib fractures are common injuries following blunt chest trauma, often requiring chest tube insertion to manage complications such as pneumothorax or haemothorax. However, chest tube placement can lead to intercostal nerve injury, resulting in intercostal neuralgia-a debilitating condition characterized by chronic, neuropathic pain along the intercostal nerves. Despite its clinical significance, the incidence, risk factors, and long-term outcomes of intercostal neuralgia in this patient population remain poorly understood. Chronic pain following thoracic trauma, including intercostal neuralgia, has been shown to significantly impair quality of life and functional outcomes, leading to prolonged disability and increased healthcare utilization. Current literature highlights the need for better understanding and management of this condition, particularly in patients undergoing invasive procedures such as chest tube insertion. This study aims to prospectively evaluate the development of intercostal neuralgia in patients with chest tube insertion following traumatic rib fractures.
Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years) with traumatic rib fractures requiring chest tube insertion * Chest tube or pigtail insertion performed during their initial hospitalization for trauma Exclusion Criteria: * Patients with spinal cord injury * Inability to complete follow-up assessments (e.g., language barriers, lack of telephone access) Exclusion Criteria: * Patients with traumatic brain injury * Patients with spinal cord injury * Inability to complete follow-up assessments (e.g., language barriers, lack of telephone access)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07308587 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intercostal Nerve Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07308587 currently recruiting?
Yes, NCT07308587 is actively recruiting participants. Contact the research team at howard.meng@sunnybrook.ca for enrollment information.
Where is the NCT07308587 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07308587 clinical trial?
NCT07308587 is sponsored by Sunnybrook Health Sciences Centre. The trial plans to enroll 100 participants.